Researchers at Boston Children’s Hospital and collaborators have developed a rapid, defined method to generate vascular organoids from human induced pluripotent stem cells via simultaneous transcription factor activation. This approach produces functional endothelial and mural cells, forming vessels that connect to host circulation after transplantation. The platform advances tissue engineering and modeling by improving vascularization, a critical hurdle in regenerative therapies.